In the realm of advanced cancer care, a crucial yet often overlooked aspect is the involvement of patients in their treatment decisions. This topic, explored in a recent doctoral thesis from the University of Agder (UiA), sheds light on a complex and deeply personal journey.
The Right to Choose
It's a legal right in Norway for patients to be involved in their treatment decisions, but the reality is far from straightforward. Patients, their families, and healthcare professionals often grapple with the practicalities of this involvement, especially when facing life-and-death choices.
A Sense of Control
For patients with incurable cancer, being included in decisions provides a sense of control and agency over their lives. It's not about understanding every medical detail but about having the knowledge to reflect on options and express what truly matters to them. This perspective is vital when choosing between treatments, especially when the effects are uncertain.
The Human Factor
One powerful example from Dr. Rabben's research highlights the importance of considering the patient's perspective. A young patient with small children, facing a slim chance of treatment success, was encouraged by the doctor to try another treatment. However, a nurse's intervention, questioning the potential side effects and their impact on family time, led to a reconsideration of priorities. This case underscores the need for honest conversations about the costs and benefits of treatment, especially in terms of quality of life.
Uncertainty and Participation
Many patients feel uncertain about their role in decision-making, questioning their knowledge and expertise. This uncertainty is exacerbated by the complex and often confusing nature of medical information. Health professionals, too, can struggle with defining the boundaries of shared decision-making, leading to a situation where patients feel ill-equipped to participate.
Shared Decision-Making: A Process, Not an Event
A key insight from Dr. Rabben's research is that shared decision-making is an ongoing process, not a one-time conversation. It involves multiple healthcare professionals and evolves over time. Conversations with nurses, for instance, can reveal patient doubts or family concerns that need addressing. However, the healthcare system's increasing fragmentation, with patients encountering a growing number of different professionals, can hinder this process.
Conclusion
As Dr. Rabben notes, Norway has made significant strides in implementing shared decision-making, but there's still a long way to go. The challenge lies in creating an environment where patients feel empowered to participate, and healthcare professionals are equipped to facilitate this involvement. It's a delicate balance, and one that requires ongoing dialogue and reflection.
